Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Alcohol use disorder and GABAB receptor gene polymorphisms in an Italian sample: haplotype frequencies, linkage disequilibrium and association studies.

Caputo F, Ciminelli BM, Jodice C, Blasi P, Vignoli T, Cibin M, Zoli G, Malaspina P.

Ann Hum Biol. 2017 Jun;44(4):384-388. doi: 10.1080/03014460.2017.1287307. Epub 2017 Feb 14.

PMID:
28118741
2.

A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.

Caputo F, Vignoli T, Tarli C, Domenicali M, Zoli G, Bernardi M, Addolorato G.

Int J Environ Res Public Health. 2016 Mar 5;13(3). pii: E290. doi: 10.3390/ijerph13030290. Review.

3.

Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.

Caputo F, Maremmani AG, Addolorato G, Domenicali M, Zoli G, D'Amore A, Maremmani I, Bernardi M.

J Psychopharmacol. 2016 Apr;30(4):402-9. doi: 10.1177/0269881116629126. Epub 2016 Feb 9.

PMID:
26860331
4.

Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence.

Pavarin RM, Caputo F, Zoli G, Domenicali M, Bernardi M, Gambini D.

Drug Alcohol Rev. 2017 Mar;36(2):186-191. doi: 10.1111/dar.12366. Epub 2015 Dec 7.

PMID:
26643015
5.

Randomised controlled trial of mesalazine in IBS.

Barbara G, Cremon C, Annese V, Basilisco G, Bazzoli F, Bellini M, Benedetti A, Benini L, Bossa F, Buldrini P, Cicala M, Cuomo R, Germanà B, Molteni P, Neri M, Rodi M, Saggioro A, Scribano ML, Vecchi M, Zoli G, Corinaldesi R, Stanghellini V.

Gut. 2016 Jan;65(1):82-90. doi: 10.1136/gutjnl-2014-308188. Epub 2014 Dec 22.

6.

Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD study.

Bortoli A, Daperno M, Kohn A, Politi P, Marconi S, Monterubbianesi R, Castiglione F, Corbellini A, Merli M, Casella G, D'Incà R, Orlando A, Bossa F, Doldo P, Lecis P, Valpiani D, Danese S, Comberlato M; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD).

J Crohns Colitis. 2014 Dec;8(12):1642-52. doi: 10.1016/j.crohns.2014.07.004. Epub 2014 Aug 10.

PMID:
25113898
7.

Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: a pilot study.

Caputo F, Del Re A, Brambilla R, Grignaschi A, Vignoli T, Vigna-Taglianti F, Addolorato G, Zoli G, Cibin M, Bernardi M.

J Psychopharmacol. 2014 Jan;28(1):23-30. doi: 10.1177/0269881113504015. Epub 2013 Sep 17.

PMID:
24045881
8.

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women.

Pedersen N, Bortoli A, Duricova D, D Inca R, Panelli MR, Gisbert JP, Zoli G, López-Sanromán A, Castiglione F, Riegler G, Annese V, Gionchetti P, Prada A, Pont ED, Timmer A, Felley C, Shuhaibar M, Tsianos EV, Dejaco C, Baert FJ, Jess T, Lebech M, Hommes DW, Munkholm P; European Crohn-Colitis Organisation-ECCO-Study Group of Epidemiology Committee-EpiCom.

Aliment Pharmacol Ther. 2013 Sep;38(5):501-12. doi: 10.1111/apt.12412. Epub 2013 Jul 15.

9.

Alcohol use in adults.

Caputo F, Zoli G, Bernardi M.

N Engl J Med. 2013 Apr 25;368(17):1654-5. doi: 10.1056/NEJMc1302445#SA1. No abstract available.

PMID:
23614599
10.

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3.

PMID:
23562264
11.

Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options.

Caputo F, Vignoli T, Leggio L, Addolorato G, Zoli G, Bernardi M.

Exp Gerontol. 2012 Jun;47(6):411-6. doi: 10.1016/j.exger.2012.03.019. Epub 2012 Apr 10. Review.

12.

Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

Sorrentino D, Terrosu G, Paviotti A, Geraci M, Avellini C, Zoli G, Fries W, Danese S, Occhipinti P, Croatto T, Zarifi D.

Dig Dis Sci. 2012 May;57(5):1341-8. doi: 10.1007/s10620-011-2025-z. Epub 2012 Jan 18.

PMID:
22252267
13.

Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.

Caputo F, Parro S, Zoli G.

J Crohns Colitis. 2011 Dec;5(6):649. doi: 10.1016/j.crohns.2011.08.017. Epub 2011 Sep 22. No abstract available.

PMID:
22115391
14.

Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.

Caputo F, Francini S, Brambilla R, Vigna-Taglianti F, Stoppo M, Del Re A, Leggio L, Addolorato G, Zoli G, Bernardi M.

Eur Neuropsychopharmacol. 2011 Jun;21(6):450-6. doi: 10.1016/j.euroneuro.2010.12.005. Epub 2011 Jan 26.

PMID:
21276717
15.

Efficacy and safety of γ-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report.

Caputo F, Bernardi M, Zoli G.

J Clin Psychopharmacol. 2011 Feb;31(1):140-1. doi: 10.1097/JCP.0b013e318203b36f. No abstract available.

PMID:
21192167
16.

[Echocardiographic evaluation of anti-tumor necrosis factor-alpha therapy with infliximab in patients without cardiac pathologies].

Bragagni G, Lari F, Magenta G, Brogna R, Zoli G.

Recenti Prog Med. 2010 Jul-Aug;101(7-8):289-92. Italian.

PMID:
20842955
17.

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data.

Mehta A, Beck M, Elliott P, Giugliani R, Linhart A, Sunder-Plassmann G, Schiffmann R, Barbey F, Ries M, Clarke JT; Fabry Outcome Survey investigators.

Lancet. 2009 Dec 12;374(9706):1986-96. doi: 10.1016/S0140-6736(09)61493-8. Erratum in: Lancet. 2010 Jan 16;375(9710):200.

PMID:
19959221
18.

Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study.

Casella G, D'Incà R, Oliva L, Daperno M, Saladino V, Zoli G, Annese V, Fries W, Cortellezzi C; Italian Group - IBD.

Dig Liver Dis. 2010 Mar;42(3):175-8. doi: 10.1016/j.dld.2009.08.005. Epub 2009 Sep 27.

PMID:
19786375
19.

Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.

Caputo F, Vignoli T, Maremmani I, Bernardi M, Zoli G.

Int J Environ Res Public Health. 2009 Jun;6(6):1917-29. doi: 10.3390/ijerph6061917. Epub 2009 Jun 24. Review.

20.

Treatment of alcohol-use disorders.

Caputo F, Bernardi M, Zoli G.

Lancet. 2009 May 2;373(9674):1519; author reply 1519-20. doi: 10.1016/S0140-6736(09)60847-3. No abstract available.

PMID:
19410705

Supplemental Content

Loading ...
Support Center